S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)
International Journal of Oncology · 2024
DOI: 10.3892/ijo.2024.5647 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Oncology, 2024. Verfasst von Mingshuai Li und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Emergency of The Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China. Hauptthemen laut MEDLINE: Biomarkers, Tumor, Epithelial-Mesenchymal Transition, S100 Proteins. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 125 Literaturangaben.
Abstract (Originalsprache)
Digestive tract cancer is one of the most common types of cancers globally, with ~4.8 million new cases and 3.4 million cancer‑associated deaths in 2018, accounting for 26% of cancer incidence and 35% of cancer‑related deaths worldwide. S100 protein family is involved in regulating cancer cell proliferation, angiogenesis, epithelial‑mesenchymal transition (EMT), metastasis, metabolism and immune microenvironment homeostasis. The critical role of S100 protein family in digestive tract cancer involves complicated mechanisms, such as cancer stemness remodeling, anaerobic glycolysis regulation, tumor‑associated macrophage differentiation and EMT. The present study systematically reviewed published studies on the compositions, function and the underlying molecular mechanisms of the S100 family, as well as guidance for diagnosis, treatment and prognosis of digestive tract cancer. Systematic review of the roles and underlying molecular mechanisms of S100 protein family may provide new insight into exploring potential cancer biomarkers and the optimized therapeutic strategies for digestive tract cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Emergency of The Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
- Central Laboratory of The First Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
- Department of Pharmacology, College of Pharmacology, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
- Department of Gastrointestinal and Anal Diseases Surgery of The Affiliated Hospital, Weifang Medical University, Weifang, Shandong 261053, P.R. China.
Zitieren
APA
Li, M., Cui, P., Dai, W., Cao, B., Zhao, H., Jin, S., Xu, D., Shi, Y., & Yan, S. (2024). S100 protein family: Emerging role and mechanism in digestive tract cancer (Review). International Journal of Oncology. https://doi.org/10.3892/ijo.2024.5647
Vancouver
Li M, Cui P, Dai W, Cao B, Zhao H, Jin S, et al. S100 protein family: Emerging role and mechanism in digestive tract cancer (Review). International Journal of Oncology. 2024. doi:10.3892/ijo.2024.5647
BibTeX
@article{Li2024,
author = {Li, Mingshuai and Cui, Peng and Dai, Wenqing and Cao, Bo and Zhao, Haobin and Jin, Shuyu and Xu, Donghua and Shi, Youkui and Yan, Shushan},
title = {S100 protein family: Emerging role and mechanism in digestive tract cancer (Review)},
journal = {International Journal of Oncology},
year = {2024},
doi = {10.3892/ijo.2024.5647}
}
EUVIMED